| Current Price | $1.35 | Mkt Cap | $109.1M |
|---|---|---|---|
| Open | $1.33 | P/E Ratio | -2.98 |
| Prev. Close | $1.35 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $1.33 - $1.42 | Volume | 90,438 |
| 52-Wk Range | $1.11 - $3.85 | Avg. Daily Vol. | 183,945 |
| Current Price | $1.35 | Mkt Cap | $109.1M |
|---|---|---|---|
| Open | $1.33 | P/E Ratio | -2.98 |
| Prev. Close | $1.35 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $1.33 - $1.42 | Volume | 90,438 |
| 52-Wk Range | $1.11 - $3.85 | Avg. Daily Vol. | 183,945 |
The best Bull and Bear pitches based on recency and number of recommendations.
There are no pitches that meet the Top Bear criteria. Explain
If this upsets you, start recommending pitches below!
Read the most recent pitches from players about PRQR.
Recs
Bigsef77
(44.91)
Submitted: 9/5/2018 10:37:52 AM :
Start Price:
$3.05
NASDAQ:PRQR Score:
-114.91
ProQR's stock rockets to pace all gainers after upbeat drug trial results
,MarketWatch•September 5, 2018
Shares of ProQR Therapeutics NV (prqr) rocketed 66% to a near 3-year high in active morning trade Wednesday, to pace gainers on all the major exchanges, after the company said results from a phase 1/2 trial for the treatment of Leber's congenital amaurosis, a cause for blindness in children, warranted the progression to a phase 2/3 trial. The company said in the trial, QR-110 demonstrated "meaningful improvement" in vision, as early as two months after treatment and was stable by three months.
Find the members with the highest scoring picks in PRQR.
yosemitebean (< 20) Score: +148.82
The Score Leader is the player with the highest score across all their picks in PRQR.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| yosemitebean | < 20 | 9/6/2018 |
|
5Y | $16.40 | -91.59% | +57.23% | +148.82 | 0 Comment | |
| XMFFlygal | 93.69 | 3/30/2023 |
|
5Y | $2.55 | -45.88% | +12.51% | +58.39 | 0 Comment | |
| PAGEBOY73 | 94.15 | 6/27/2023 |
|
1Y | $1.63 | -15.34% | +4.45% | +19.79 | 0 Comment | |
| ershler | 81.27 | 6/27/2023 |
|
5Y | $1.61 | -14.29% | +5.15% | +19.44 | 0 Comment | |
| jrbecb | < 20 | 1/17/2023 |
|
5Y | $3.52 | -60.76% | +14.27% | -75.03 | 0 Comment | |
| kfassini | < 20 | 2/26/2021 |
|
5Y | $4.39 | -68.56% | +19.33% | -87.90 | 0 Comment | |
| TruffelPig | < 20 | 5/18/2021 |
|
5Y | $6.51 | -78.80% | +9.34% | -88.14 | 0 Comment | |
| Bigsef77 | 44.91 |
|
|
3Y | $3.05 | -54.75% | +60.15% | -114.91 | 1 Comment | |
| portefeuille3 | 91.10 | 12/27/2017 |
|
5Y | $3.04 | -54.61% | +69.98% | -124.59 | 0 Comment | |
| beecha | 44.70 | 9/19/2017 |
|
5Y | $6.25 | -77.92% | +81.85% | -159.77 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
